NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the pricing of its underwritten public offering of...
Hence then, the article about lucid diagnostics announces pricing of public offering of common stock was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Pricing of Public Offering of Common Stock )
Also on site :
- Mountain lion spotted in San Francisco's Pacific Heights neighborhood
- Sydney Sweeney gives first look at forthcoming lingerie brand, Syrn, in black lace
- HGTV Star Signals a Return After Network Cancellations: 'Don’t You Worry'